AI Health & Biotechnology
AI Oncology Tools Shine at ASCO Breakthrough 2026
New clinical AI identifies trial patients and predicts pancreatic cancer outcomes during Singapore's major summit.
A modern medical conference setting featuring large digital displays of AI-driven cancer research and a group of oncologists observing a clinical presentation.
Photo: Kronos Digital News
The 2026 ASCO Breakthrough meeting in Singapore highlighted significant progress in clinical artificial intelligence [1]. Researchers presented tools that automatically identify eligible patients for clinical trials to speed up research [1]. These innovations aim to streamline complex medical workflows in global oncology centers [3].
New multi-modal AI models are now predicting how pancreatic cancer patients respond to specific treatments [1]. Beyond AI, the summit showcased advancements in cellular therapy and antibody-drug conjugates [2]. These combined technologies represent a shift toward more personalized cancer care [2][3].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
Related stories
View all
Topics
About the author
Kronos Digital News Desk covers ai health & biotechnology and editorial analysis for Kronos Digital News.